跳到正文
原文
STAT 主站· Bob Herman·· 22 天前精选AI 评分70

美国联邦敲定新规,要求 PBM 向雇主披露返点与价差等全部报酬

STAT+: New federal rule will require prescription drug middlemen to share secret payments data

AI 导读

特朗普政府周四敲定一项法规,要求为雇主和员工管理药品支出的药品福利管理机构(PBM)向雇主披露其从药企、咨询公司等获得的全部费用与报酬。披露内容包括药品返点、价差定价,以及与经纪商、顾问之间可能产生利益冲突的财务关系,自 2027 年 7 月 1 日起执行。联邦官员估计该规则将覆盖 70 多家 PBM 和 13 万家雇主,每年通过降低药价节省逾 8 亿美元。

推荐理由

新规要求 PBM 披露返点与价差等全部报酬,读者可据此判断药品中间环节费用透明化的推进节奏。

正文

PBMs, lobbyists previously warned they may take legal action over Trump’s proposal

Adobe

By Bob Herman

Oct. 29, 2026

Bob Herman is the author of Health Care Inc., an award-winning weekly newsletter about the business of health and medicine.

Bob covers the money in health care, focusing on health insurance and hospitals. His stories delve into Medicare Advantage, opaque prescription drug benefits, and how much executives actually make. He is also the author of the Health Care Inc. newsletter. You can reach Bob on Signal at bobjherman.09.

The middlemen that oversee prescription drug spending for employers and workers will soon have to tell their clients all the different ways they get paid, a significant move that will unlock reams of highly protected data.

The Trump administration finalized a regulation Thursday that will force pharmacy benefit managers to disclose all the different fees and compensation they get from drugmakers, consulting firms, and other entities to the employers that hire them. The disclosures — which will be required starting on July 1, 2027 — will include drug rebates, spread pricing, and financial relationships with brokers and consultants that could create conflicts of interest. 

Federal officials estimate the rule will apply to more than 70 PBMs and 130,000 employers, saving more than $800 million annually through lower drug costs.

STAT+ Exclusive Story

Already have an account? Log in

STAT+

STAT+

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

Already have an account? Log in

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe

  1. Business of Health Care Reporter

    Bob covers the money in health care, focusing on health insurance and hospitals. His stories delve into Medicare Advantage, opaque prescription drug benefits, and how much executives actually make. He is also the author of the Health Care Inc. newsletter. You can reach Bob on Signal at bobjherman.09.

来源:STAT 主站 · statnews.com